首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1905022

全球智慧電網市場：按技術、應用和地區分析－市場規模、產業趨勢、機會分析和預測（2026-2035）

Global FemTech Market: By Offering, Applications, Distribution Channel, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035

出版日期: 2026年01月06日 | 出版商:

Astute Analytica | 英文 256 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球智慧電網市場正經歷強勁擴張期，反映出市場對能夠應對現代電網挑戰的先進能源系統的需求日益增長。 2025年，該市場規模將達到525.5億美元，顯示全球對智慧電網技術的投資龐大且應用廣泛。預計未來十年，這一成長動能將顯著加速，到2035年將達到2,591.5億美元。這一成長軌跡意味著2026年至2035年預測期內的複合年增長率將高達17.30%，顯示全球對升級電力基礎設施的濃厚興趣持續存在。

推動市場快速成長的關鍵因素很多。首要催化劑是迫切需要對老化的電力基礎設施進行現代化改造。這些系統大多設計於幾十年前，已無法滿足當今不斷變化的能源需求。現代化改造的重點在於用智慧系統取代過時的設備，以實現即時監控、自動化和數據驅動的決策。同時，風能、太陽能和分散式發電等再生能源的併網正在加速，這需要更智慧的電網解決方案來有效管理這些資源的間歇性和分散性。最後，人們越來越重視提高能源效率，並增強電網抵禦極端天氣、網路威脅和其他挑戰造成的干擾的能力。

市場趨勢

智慧電網市場的競爭格局明顯有利於那些成功採用數位智慧和先進技術的成熟產業領導者。這些公司正在利用其豐富的經驗和資源來滿足對智慧電網解決方案的激增需求。目前，由於普遍存在的容量限制，需求超過了供應。這種供需失衡造成了前所未有的訂單積壓，既反映了公用事業公司和政府迫切需要對其電力基礎設施進行現代化改造，也反映了製造商在快速擴大生產規模方面面臨的挑戰。

主要市場參與者包括西門子、施耐德電機、通用電氣 (GE)、ABB、Itron 和 IBM 等全球性公司。這些公司利用其廣泛的產品組合、技術專長和全球影響力，提供全面的智慧電網解決方案，以滿足全球公用事業公司的多樣化需求。除了這些行業巨頭之外，專業技術供應商也發揮關鍵作用，他們提供的創新技術可以補充和增強領先企業的能力。

智慧電網發展的一個顯著例子是摩洛哥於 2025 年 11 月啟動了非洲首個智慧電網平台，這是確保該國能源未來的決定性一步。這項由國家電力和飲用水公司 (ONEE) 發起並於當月早些時候在電力科學技術中心宣布的開創性舉措，標誌著非洲大陸能源轉型工作取得了重大進展。本計畫由非洲開發銀行資助，投資額超過400萬迪拉姆，不僅彰顯了摩洛哥對永續能源的承諾，也鞏固了摩洛哥在智慧電網創新領域的非洲大陸領先地位。

主要成長驅動因素

推動智慧電網市場快速成長的關鍵因素是風能和太陽能等可變再生能源的爆炸性成長。在環境問題和減少碳排放的政策要求的推動下，這些再生能源正處於全球向更清潔、更永續的能源系統轉型努力的核心。然而，可變再生能源固有的間歇性和不可預測性給電網營運商帶來了巨大挑戰，他們必須即時平衡供需以維持電網的穩定性和可靠性。與提供穩定、可控輸出的傳統發電廠不同，再生能源會隨天氣狀況波動，產生傳統電網基礎設施難以應對的複雜問題。

新機會趨勢

人工智慧 (AI) 和氣候韌性在重塑智慧電網市場方向方面發揮著日益重要的作用。隨著電網變得日益複雜，尤其是在分散式能源興起的情況下，電力公司正轉向生成式人工智慧技術，以更有效地管理這種複雜性。人工智慧的應用正在蓬勃發展，因為這些先進的演算法為電力公司提供了強大的工具，用於優化電網運行、預測需求以及無縫整合各種能源。透過即時分析大量數據，人工智慧能夠實現更智慧的決策，提高營運效率，並幫助電力公司主動應對電網中的波動和中斷。

優化障礙

雖然智慧電網市場隨著連接性和數位化整合的增強而不斷發展，但也增加了遭受網路攻擊的風險，為電力系統帶來了重大風險。雖然提高設備、感測器和通訊網路之間的互聯互通對於提高電網的效率和回應能力至關重要，但同時也擴大了惡意行為者的攻擊面。網路威脅，包括破壞、欺騙和中間人攻擊，正變得日益複雜，並瞄準電網基礎設施的關鍵組件，擾亂運行、竊取敏感資料並造成大範圍停電。

產業價值鏈分析
- 原料供應商
- 製造商
- 經銷商
- 終端用戶
行業展望
- 全球電力生產
- 全球電力消費
PESTLE分析
波特五力分析
- 供應商議價能力
- 買方議價能力
- 替代品威脅
- 新進入者威脅
- 競爭強度
市場成長與展望
- 市場收入估計與預測（2020-2035）
- 價格趨勢分析技術
市場吸引力分析
- 依技術分類
- 依地區分類
可操作的洞見（分析師建議）

第四章：競爭格局概覽

市場集中度
公司佔有率分析（基於價值，2025 年）
競爭格局分析與基準分析

第五章：全球智慧電網市場分析

市場動態與趨勢
- 成長驅動因素
- 限制因素
- 機遇
- 關鍵趨勢
市場規模及預測（2020-2035 年）
- 按技術
  - 進階計量基礎設施 (AMI)
  - 配電管理
  - 變電站自動化
  - 通信
  - 安全
  - 網路管理
- 按應用領域劃分
  - 發電
  - 輸電
  - 配電
  - 用電
- 按地區劃分

第六章：北美智慧電網市場分析

第七章：歐洲智慧電網市場分析

第八章：亞太地區智慧電網市場分析

第九章：中東與非洲智慧電網市場分析

第十章：南美洲智慧電網市場分析

第十一章：公司公司簡介

ABB
Aclara
思科
伊頓
通用電氣
霍尼韋爾
IBM
Itron
蘭吉爾
甲骨文
S&C電氣公司
施耐德電機
西門子
威普羅有限公司
其他主要參與者

第十二章：附錄

簡介目錄

Product Code: AA0124751

The FemTech (Female Technology) market, which centers on digital solutions designed to address women's health needs, is undergoing remarkable expansion. Valued at approximately US$ 63.14 billion in 2025, the market is projected to reach an impressive valuation of US$ 266.99 billion by 2035. This forecasted growth represents a robust compound annual growth rate (CAGR) of 15.51% durimg the period from 2026 to 2035, signaling a rapidly evolving and increasingly vital sector within the broader healthcare technology landscape. The surge in market value reflects both the expanding recognition of women's unique health requirements and the rising integration of advanced technologies that cater specifically to those needs.

Several key factors are driving this accelerated growth in the FemTech market. One of the primary catalysts is the increasing awareness around women's health issues, which has helped break down traditional stigmas and promote more open discussions. As public understanding improves, more women are actively seeking solutions that address their specific health concerns, ranging from reproductive health to menstrual care, sexual wellness, and broader general health management. This growing awareness fuels demand not only for products but also for services that can provide meaningful support and empowerment in managing health.

Noteworthy Market Developments

The competitive hierarchy within the FemTech market has increasingly solidified around players who have successfully integrated clinical efficacy with consumer-friendly technology, creating a new benchmark for success in the industry. Competition is no longer confined to emerging startups alone; it now spans a broader spectrum where nimble startups face off against established legacy healthcare institutions. This evolving dynamic is shaped by the fact that hospitals and maternal centers continue to command a substantial 46.54% share of the market's revenue, underscoring their enduring influence and the trust they hold within the healthcare ecosystem.

Recent developments illustrate the intensity and diversity of competition in this space. In January 2026, OTO Fertility, a division of the Canada-based company OTO Coach, launched a groundbreaking platform that combines a clinical-grade wearable biosensor with an FDA-approved application designed to predict fertility treatment outcomes. This innovation exemplifies how startups are leveraging advanced technology and regulatory validation to offer clinically robust solutions directly to consumers. Meanwhile, in December 2025, Ovum and AKQA announced a strategic partnership aimed at accelerating AI-powered women's health innovation.

Further reflecting the competitive vibrancy of the market, November 2025 saw IdentifyHer open US pre-orders for Peri, a wearable device specifically designed to detect and track perimenopause symptoms. This product addresses a critical and often underrepresented segment of women's health, highlighting the growing focus on personalized monitoring and symptom management during transitional life stages. In the same month, Bristol-based startup Emm successfully raised £6.8 million in an oversubscribed seed funding round to bring the world's first smart menstrual cup and connected app to market.

Core Growth Drivers

Increasing awareness and growing demand are key forces propelling the FemTech market forward, fueling its rapid expansion and shaping its future trajectory. Over recent years, there has been a marked shift in societal attitudes toward women's health, with more open discussions and education helping to break down long-standing taboos. This heightened awareness has empowered women to prioritize their health and seek out innovative solutions tailored specifically to their unique needs. As a result, more women are becoming informed about the availability and benefits of FemTech products and services, leading to a significant increase in consumer interest and willingness to adopt these technologies.

Emerging Opportunity Trends

Technological advancements and improved access are emerging as powerful catalysts driving the adoption of FemTech solutions, presenting a significant opportunity for market growth. Rapid innovation in areas such as artificial intelligence, wearable sensors, mobile health applications, and telemedicine has transformed the landscape of women's healthcare, making it more personalized, accessible, and efficient. These cutting-edge technologies enable FemTech products to offer real-time monitoring, predictive analytics, and tailored health recommendations, which greatly enhance user engagement and health outcomes. As a result, women are increasingly empowered to take control of their health journeys with tools that are both convenient and clinically reliable.

Barriers to Optimization

Persistent social stigma surrounding women's health continues to pose a significant barrier to the growth of the FemTech market. Despite increasing awareness and progressive conversations around women's health issues, many topics remain taboo or uncomfortable to discuss openly in various cultures and communities worldwide. This stigma often discourages women from seeking timely medical advice, utilizing health technologies, or purchasing products related to sensitive areas such as menstruation, fertility, sexual health, and menopause. As a result, the market faces challenges in reaching a broader audience and fully unlocking the potential demand for FemTech solutions.

Detailed Market Segmentation

By Offerings, the FemTech equipment segment holds a dominant position in the overall FemTech market, commanding a substantial 45.46% share of total revenue. This dominance is largely due to the high unit cost associated with medical-grade hardware, which naturally contributes to larger revenue figures compared to software or service-based offerings. More importantly, the market is witnessing a significant shift toward clinical-grade home care, where consumers increasingly seek reliable, professional-level devices that can be used conveniently in the comfort of their own homes. This trend reflects a broader movement in healthcare toward decentralization and personalized care, where patients are empowered with sophisticated tools to monitor and manage their health outside of traditional clinical settings.

By Application, the pregnancy and nursing segment commands a substantial 30.98% share of the FemTech market, reflecting its critical role in addressing one of the most medically intensive and emotionally significant periods in a woman's life. This phase involves heightened healthcare needs and complexities, making it a focal point for technological innovation and specialized medical support. Women during pregnancy and nursing are often highly motivated to invest in products and services that provide safety, comfort, and reassurance, which drives a strong willingness to pay. This financial commitment is further amplified by increasing awareness of maternal health risks, prompting demand for advanced monitoring and care solutions that can help mitigate complications and ensure the well-being of both mother and child.

By Distribution Channel, Retail channels play a pivotal role in the women's health market, contributing a significant 51.85% of the total revenue. This strong performance is fueled by the growing mainstream destigmatization of women's health issues, which has encouraged more open conversations and acceptance around topics that were once considered taboo. As a result, a wider demographic of consumers feels comfortable seeking out and purchasing health products through traditional retail outlets. This cultural shift has been instrumental in driving more traffic to physical stores and legitimizing retail channels as trusted sources for women's health solutions.

Segment Breakdown

By Offering

Equipment
Fertility Tracker
Breast Feeding Pumps
Monitoring Devices
Pregnancy and Ovulation Testing Kits
Wearables
Others
Digital Platforms/Applications
Consumables
Therapeutic Drugs
Vitamins & Supplements
Others
Services

By Application

Reproductive Health & Contraception
Pregnancy & Nursing
Menstrual Health
Mental Health
General Health & Wellness
Others

By Distribution Channel

Retail
Online

By Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of MEA
South America
Argentina
Brazil
Rest of South America

Geography Breakdown

North America continues to dominate the global FemTech market, firmly establishing itself as the undisputed heavyweight with a commanding 38.64% share of the total market in 2024. This dominant position is largely driven by the United States, which alone accounts for an impressive 89.2% of the region's total revenue. The strength of the North American FemTech market can be attributed to several unique factors, including the region's innovative approach to healthcare benefits, corporate culture, and early adoption of technology-driven solutions aimed at women's health.
A key element underpinning this dominance is the distinctive "employer-pay" model prevalent in North America, particularly in the U.S. In this model, companies proactively offer comprehensive fertility and menopause-related benefits as part of their employee wellness programs. This approach is motivated by a growing recognition that supporting women's health is essential for talent retention and workforce productivity. Employers view investments in FemTech solutions not only as a way to enhance employee well-being but also as a strategic tool to attract and retain top talent in competitive industries.

Leading Market Participants

Ava Sciences
Baymatob Operations Pty. Ltd
Bonzun
Carrot
Chiaro Technology Limited (Elvie)
Clue (Biowink GmbH)
Flo Health
Glow Inc.
Kindbody (KBI Services, Inc.)
Maven Clinic
Natural Cycles
RO Health Inc.
Willow Innovations, Inc
Other Prominent Players

Table of Content

Chapter 1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

Chapter 2. Research Methodology

2.1. Qualitative Research
- 2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
- 2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation

Chapter 3. Executive Summary: Global FemTech Market

Chapter 4. Global FemTech Market Overview

4.1. Industry Value Chain Analysis
- 4.1.1. Service Provider
- 4.1.2. End User
4.2. Industry Outlook
- 4.2.1. Overview of FemTech Industry Development
- 4.2.2. Overview on FemTech Investment
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers
- 4.4.2. Bargaining Power of Buyers
- 4.4.3. Threat of Substitutes
- 4.4.4. Threat of New Entrants
- 4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
- 4.5.1. Growth Drivers
  - 4.5.1.1. The rise of VC funding for FemTech
- 4.5.2. Restraints
- 4.5.3. Challenges
- 4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
- 4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2035
4.8. Competition Dashboard
- 4.8.1. Market Concentration Rate
- 4.8.2. Company Market Share Analysis (Value %), 2025
- 4.8.3. Competitor Mapping

Chapter 5. Global FemTech Market Analysis, By Offering

5.1. Key Insights
5.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 5.2.1. Equipment
  - 5.2.1.1. Fertility Tracker
  - 5.2.1.2. Breast Feeding Pumps
  - 5.2.1.3. Monitoring Devices
  - 5.2.1.4. Pregnancy and Ovulation Testing Kits
  - 5.2.1.5. Wearables
  - 5.2.1.6. Others
- 5.2.2. Digital Platforms/Applications
- 5.2.3. Consumables
  - 5.2.3.1. Therapeutic Drugs
  - 5.2.3.2. Vitamins & Supplements
  - 5.2.3.3. Others
- 5.2.4. Services

Chapter 6. Global FemTech Market Analysis, By Application

6.1. Key Insights
6.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 6.2.1. Reproductive Health & Contraception
- 6.2.2. Pregnancy & Nursing
- 6.2.3. Menstrual Health
- 6.2.4. Mental Health
- 6.2.5. General Health & Wellness
- 6.2.6. Others

Chapter 7. Global FemTech Market Analysis, By Distribution Channel

7.1. Key Insights
7.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 7.2.1. Retail
- 7.2.2. Online

Chapter 8. Global FemTech Market Analysis, By Region

8.1. Key Insights
8.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 8.2.1. North America
  - 8.2.1.1. The U.S.
  - 8.2.1.2. Canada
  - 8.2.1.3. Mexico
- 8.2.2. Europe
  - 8.2.2.1. Western Europe
    - 8.2.2.1.1. The UK
    - 8.2.2.1.2. Germany
    - 8.2.2.1.3. France
    - 8.2.2.1.4. Italy
    - 8.2.2.1.5. Spain
    - 8.2.2.1.6. Rest of Western Europe
  - 8.2.2.2. Eastern Europe
    - 8.2.2.2.1. Poland
    - 8.2.2.2.2. Russia
    - 8.2.2.2.3. Rest of Eastern Europe
- 8.2.3. Asia Pacific
  - 8.2.3.1. China
  - 8.2.3.2. India
  - 8.2.3.3. Japan
  - 8.2.3.4. South Korea
  - 8.2.3.5. Australia & New Zealand
  - 8.2.3.6. ASEAN
  - 8.2.3.7. Rest of Asia Pacific
- 8.2.4. Middle East & Africa
  - 8.2.4.1. UAE
  - 8.2.4.2. Saudi Arabia
  - 8.2.4.3. South Africa
  - 8.2.4.4. Rest of MEA
- 8.2.5. South America
  - 8.2.5.1. Argentina
  - 8.2.5.2. Brazil
  - 8.2.5.3. Rest of South America

Chapter 9. North America FemTech Market Analysis

9.1. Key Insights
9.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 9.2.1. By Offering
- 9.2.2. By Application
- 9.2.3. By Distribution Channel
- 9.2.4. By Country

Chapter 10. Europe FemTech Market Analysis

10.1. Key Insights
10.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 10.2.1. By Offering
- 10.2.2. By Application
- 10.2.3. By Distribution Channel
- 10.2.4. By Country

Chapter 11. Asia Pacific FemTech Market Analysis

11.1. Key Insights
11.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 11.2.1. By Offering
- 11.2.2. By Application
- 11.2.3. By Distribution Channel
- 11.2.4. By Country

Chapter 12. Middle East and Africa FemTech Market Analysis

12.1. Key Insights
12.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 12.2.1. By Offering
- 12.2.2. By Application
- 12.2.3. By Distribution Channel
- 12.2.4. By Country

Chapter 13. South America FemTech Market Analysis

13.1. Key Insights
13.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
- 13.2.1. By Offering
- 13.2.2. By Application
- 13.2.3. By Distribution Channel
- 13.2.4. By Country